ACRPO  >> Vol. 1 No. 2 (October 2012)

    Effect of Recombinant Endostatin in Combination with Radiotherapy on the Expression of TGF-β1 and HIF-1α in Lung Adenocarcinoma Cell A549

  • 全文下载: PDF(432KB) HTML   XML   PP.5-10   DOI: 10.12677/ACRPO.2012.12002  
  • 下载量: 1,650  浏览量: 7,613   国家自然科学基金支持


介芳芳,曹德东,戈 伟,徐细明,李长虎,黄 玉,刘 梁,郑永法:武汉大学人民医院肿瘤中心;
杨 芳:武汉大学基础医学院

重组人血管内皮抑素放射治疗转化生长因子-β1乏氧诱导因子-1α肺腺癌Endostar; Radiotherapy; Transforming Growth Factor-Beta 1; Hypoxia Induced Factor-1α; Lung Adenocarcinoma


通过观察Endostar联合放疗对肺腺癌A549细胞增值及TGF-β1HIF-1α表达的影响,初步探讨重组血管内皮抑素的放疗增敏机制。方法:将培养至对数生长期的A549细胞分为对照组、单纯放疗组、恩度组、联合组,检测各组A549细胞增殖率及TGF-β1HIF-1α蛋白和mRNA表达情况。结果:1) 除对照组外,各组细胞的增殖随时间的改变都受到不同程度的抑制,以联合组最为明显,差异具有统计学意义(p < 0.05)2) 处理后各组A549细胞TGF-β1HIF-1α的分泌下降,24 h以放疗组及联合组TGF-β1HIF-1α表达量明显下降 (p < 0.05)3) PCR扩增后,各处理组 TGF-β1HIF-1α mRNA的表达随着时间变化均表现出下降趋势,联合组在24 h差异有显著统计学意义(p < 0.05)结论:恩度联合放疗可显著抑制肺腺癌A549细胞增殖及TGF-β1HIF-1α的表达,恩度可能通过下调TGF-β1HIF-1α的表达进而发挥放疗增敏作用。
To observe the effect of Endostar combined with Radiotherapy on the expression of Transforming Growth Factor-beta 1 (TGF-β1) and Hypoxia-induced factor-1 (HIF-1α) in lung adenocarcinoma A549 cells and to discuss the possible mechanisms. Methods: To culture the A549 cell, when the cells achieve Logarithmic phase and there are four groups: Control group; Endostar group; Radiotherapy group; Endostar in combination with Radiotherapy. Cell proliferate rate was measured by CCK8, and the expression level of TGF-beta 1 and HIF-1α protein and mRNA of A549 cells in each group were examined by ELISA and PCR. Result: 1) Besides control group, the proliferation of tumor cells in each group are subject to different degree of inhibition. Compared with control and Endostar groups, there is a significant difference of proliferate inhibition in Endostar combined with Radiotherapy group (p < 0.05). 2) After treatment, the expressions of TGF-β1 and HIF-1 of A549 cells in each group appears to be declining differently. The Radiotherapy group and combined group have a significant difference in cell proliferation at 24 hours, compared to control group (p < 0.05). 3) After PCR amplification, the changes of expressions of TGF-β1 and HIF-1α mRNA over time (0 - 24 hours) compared with the control group, all treatment groups showed a decreasing trend. After 24 hours of treatment, Compared with control group and Endostar group, the difference in the combined group was statistically sig- nificant (p < 0.05). Conclusion: Endostar combined with Radiotherapy could significantly enhance the inhibition of proliferate of cells and expressions of TGF-β1 and HIF-1α in tumor cells. Thus enhance the inhibition of tumor angio- genesis and metastatic.

介芳芳, 曹德东, 戈伟, 徐细明, 李长虎, 杨芳, 黄玉, 刘梁, 郑永法. 重组人血管内皮抑素联合放疗对肺腺癌A549细胞TGF-β1、HIF-1α表达的影响[J]. 亚洲肿瘤科病例研究, 2012, 1(2): 5-10.


[1] M. Kamrava, M. B. Bernstein, K. Camphausen, et al. Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: The three musketeers or just another quixotic combination? Molecular Biosystems, 2009, 5(11): 1262- 1270.
[2] J. Folkman. Antiangiogenesis in cancer therapy—Endostatin and its mechanisms of action. Experimental Cell Research, 2006, 312(5): 594-607.
[3] 林丽彬, 林建银. 内皮抑素及其抗血管生成作用[J]. 福建医科大学学报, 2007, 41(2): 189-190.
[4] 王金万, 孙燕, 刘永煜等. 重组人血管内皮抑素联合NP方案治疗晚期NSCLC随机、双盲、对照、多中心Ⅲ期临床研究[J]. 中国肺癌杂志, 2005, 8(4): 283-290.
[5] Z. Y. You, Y. Zhao, F. Liu, et al. The radiosensitization effects of Endostar on human lung squamous cancer cells H-520. Cancer Cell International, 2010, 10: 17.
[6] R. Feng, X. J. Huang. Preliminary study on the anti-leukemia effect of recombinant human endostatin. National Medical Journal of China, 2010, 31(7): 461-465.
[7] Y. T. Jia, Z. X. Li, M. Liu, et al. Endostar reduces the growth and metastasis by inhibiting angiogenesis and lymphangiogenesis in nude mouse models of human cervical cancer. National Medical Journal of China, 2009, 31(4): 254-257.
[8] C. H. Heldin, M. Landström and A. Moustakas. Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial- mesenchymal transition. Current Opinion in Cell Biology, 2009, 21(2): 166-176.
[9] S. Serratì, F. Margheri, M. Pucci, et al. TGF-beta1 antagonistic peptides inhibit TGF beta1-dependent angiogenesis. Biochemi-cal Pharmacology, 2009, 77(5): 813-825.
[10] K. S. Chae, M. J. Kang, J. H. Lee, et al. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hy- poxic conditions. Oncogene, 2010 (Epub ahead of print).
[11] L. Zhang, W. Ge, K. Hu, Y. Zhang, et al. Endostar down-regu- lates HIF-1 and VEGF expression and enhances the radiore-sponse to human lung adenocarcinoma cancer cells. Molecular Biology Reports, 2012, 39(1): 89-95.
[12] G. L. Semenza. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene, 2010, 29(5): 625- 634.
[13] S. Kitamura, Y. Maeshima, T. Sugaya, et al. Transforming growth factor-1 induces vascular endothelial growth factor expression in murine proximal tubular epithelial cells. Nephron Experimental, 2003, 95: 79-86.
[14] H. H. Lin, C. W. Tsai, F. P. Chou, et al. Andrographolide down- regulates hypoxia-inducible factor-1α in human non-small cell lung cancer A549 cells. Toxicology and Applied Pharmacology, 2011, 250(3): 336-345.